GFP
BMY icon

Gryphon Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Gryphon Financial Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
+4,157
New +$239K 0.02% 350
2024
Q2 		– Sell
-4,765
Closed -$258K – 269
2024
Q1 		$258K Sell
4,765
-470
-9% -$23.9K 0.04% 224
2023
Q4 		$280K Buy
5,235
+995
+23% +$52.2K 0.05% 196
2023
Q3 		$246K Buy
4,240
+664
+19% +$40.7K 0.06% 160
2023
Q2 		$229K Sell
3,576
-1,768
-33% -$119K 0.05% 176
2023
Q1 		$370K Sell
5,344
-529
-9% -$37.3K 0.08% 131
2022
Q4 		$423K Sell
5,873
-521
-8% -$39.3K 0.1% 112
2022
Q3 		$454K Buy
6,394
+595
+10% +$43.2K 0.11% 101
2022
Q2 		$447K Buy
5,799
+1,599
+38% +$122K 0.11% 107
2022
Q1 		$307K Buy
4,200
+71
+2% +$4.77K 0.06% 156
2021
Q4 		$257K Sell
4,129
-313
-7% -$18.4K 0.05% 176
2021
Q3 		$262K Sell
4,442
-552
-11% -$36.4K 0.06% 168
2021
Q2 		$321K Buy
4,994
+903
+22% +$58.9K 0.07% 136
2021
Q1 		$257K Buy
4,091
+30
+0.7% +$1.87K 0.06% 147
2020
Q4 		$252K Sell
4,061
-604
-13% -$37.1K 0.06% 136
2020
Q3 		$282K Buy
+4,665
New +$281K 0.08% 124
2020
Q2 		– Sell
-4,626
Closed -$257K – 138
2020
Q1 		$257K Sell
4,626
-1,794
-28% -$110K 0.09% 118
2019
Q4 		$412K Buy
+6,420
New +$368K 0.11% 108
2018
Q4 		– Sell
-5,892
Closed -$366K – 196
2018
Q3 		$366K Buy
5,892
+3,258
+124% +$193K 0.11% 97
2018
Q2 		$146K Sell
2,634
-160
-6% -$8.64K 0.07% 102
2018
Q1 		$177K Sell
2,794
-34
-1% -$2.19K 0.09% 86
2017
Q4 		$173K Buy
+2,828
New +$177K 0.1% 91

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gryphon Financial Partners's BMY Position: Q2 2026 in Review

Gryphon Financial Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,157 shares worth $240K. The stake represents 0.02% of the portfolio and ranks #350 among its holdings. This is a return to the name: Gryphon Financial Partners previously reported a position in BMY as recently as Q1 2024.

Gryphon Financial Partners first reported a position in BMY in Q4 2017 and has held it in 22 quarters since. The position peaked at $454K in Q3 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Gryphon Financial Partners held 4,157 shares of Bristol-Myers Squibb worth $240K as of Q2 2026.
  • Bristol-Myers Squibb was a new Gryphon Financial Partners position in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Gryphon Financial Partners's portfolio in Q2 2026, its #350 holding.
  • Gryphon Financial Partners first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 22 quarters since.
  • Gryphon Financial Partners's Bristol-Myers Squibb position peaked at $454K in Q3 2022.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.